AU Stock MarketDetailed Quotes
ATH Alterity Therapeutics Ltd
- 0.003
- 0.0000.00%
20min DelayNot Open Sep 17 15:57 AET
15.94MMarket Cap-600P/E (Static)
0.004High0.003Low2.59MVolume0.003Open0.003Pre Close7.88KTurnover0.00852wk High0.05%Turnover Ratio5.31BShares0.00252wk Low-0.005EPS TTM14.84MFloat Cap0.033Historical HighLossP/E (Static)4.95BShs Float0.002Historical Low-0.005EPS LYR33.33%Amplitude--Dividend TTM1.00P/B1Lot Size--Div YieldTTM
Alterity Therapeutics Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 8.58M | 3.91M | 0 | 4.68M | ||||||
| Revenue from customers | ---- | --0 | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Income from government grants | ---- | --0 | --3.91M | --0 | --4.68M | ---- | ---- | --0 | ---- | ---- |
| Other cash income from operating activities | --8.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid | -21.45M | -5.8M | -67.05%-6.53M | -4.88M | 11.62%-4.21M | -7.31%-3.91M | 6.91%-4.77M | |||
| Payments to suppliers for goods and services | ---21.39M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid on behalf of employees | ---- | ---746K | 25.60%-872K | ---922K | 8.59%-830K | ---- | ---- | -30.80%-1.17M | ---- | -13.08%-908K |
| Other cash payments from operating activities | ---- | ---5M | -106.77%-5.65M | ---3.96M | 9.96%-3.38M | ---- | ---- | 0.36%-2.73M | ---- | 13.00%-3.76M |
| Direct dividend received | ---- | --0 | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Direct interest paid | ---7.22K | --0 | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Direct interest received | --269.08K | --126K | 2,050.00%43K | --17K | --82K | ---- | ---- | --2K | ---- | ---- |
| Direct tax refund paid | ---58.02K | ---57K | --0 | --0 | --0 | ---- | ---- | --0 | ---- | ---102K |
| Operating cash flow | ---12.61M | ---5.67M | 33.99%-2.58M | ---4.86M | 111.52%549K | ---- | ---- | -14.42%-3.9M | ---- | 2.62%-4.77M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 84.31%-5.72K | 0 | 0 | 79.50%-1K | -4K | 59.10%-36.46K | 70.18%-26.58K | -5K | -90.58%-4.88K | 0 |
| Net PPE purchase and sale | 21.73%-5.72K | --0 | --0 | 79.50%-1K | ---4K | 91.80%-7.31K | 102.88%2.57K | ---5K | -90.58%-4.88K | --0 |
| Net intangibles purchas and sale | ---- | --0 | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Net business purchase and sale | ---- | --0 | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Net investment purchase and sale | ---- | --0 | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Dividends received (cash flow from investment activities) | ---- | --0 | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---29.15K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 84.31%-5.72K | --0 | --0 | 79.50%-1K | ---4K | 59.10%-36.46K | 70.18%-26.58K | ---5K | -90.58%-4.88K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 7,312.17%9.22M | 546.64%57K | 6,501.60%8.25M | 990.74%970K | -114.05%-17K | -99.24%124.34K | 95.53%-12.76K | 12,400.00%125K | 59.51%-108.9K | -99.27%121K |
| Net issuance payments of debt | 82.69%-10.37K | 255.50%50K | --0 | --0 | --0 | -73.62%-59.92K | 6.84%-32.15K | --0 | -16.89%-27.77K | --0 |
| Net common stock issuance | 3,103.50%10.14M | 671.47%45K | 4,803.30%8.92M | 712,758.23%1.13M | --0 | -98.16%316.68K | 14,482.50%5.83K | --182K | -495.00%-158 | -99.25%129K |
| Cash dividends paid | ---- | --0 | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Proceeds from stock option exercised by employees | ---- | --0 | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Net other financing activities | -593.30%-918.02K | -380.26%-38K | -1,080.70%-673K | -92.66%-156K | -112.50%-17K | 84.18%-132.41K | 105.40%13.56K | -5,800.00%-57K | 66.98%-80.97K | 98.58%-8K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 7,312.17%9.22M | 546.64%57K | 6,500.80%8.25M | 990.74%970K | -114.05%-17K | -99.24%124.34K | 95.53%-12.76K | 12,400.00%125K | 59.51%-108.9K | -99.27%121K |
| Net cash flow | ||||||||||
| Beginning cash position | -54.68%15.77M | -16.60%18.3M | -51.40%12.32M | -47.54%16.71M | -54.68%15.77M | 23.80%34.81M | -32.76%21.94M | -31.49%25.35M | -22.95%31.85M | 23.80%34.81M |
| Current changes in cash | 82.98%-3.4M | 10.08%-5.62M | 249.95%5.67M | 26.14%-3.89M | 111.37%528K | -614.37%-19.95M | -1,645.52%-6.25M | -10.94%-3.78M | -30.23%-5.27M | -139.64%-4.65M |
| Effect of exchange rate changes | -71.54%260.36K | -151.08%-45K | -18.78%307K | 60.05%-495K | -75.83%408K | -67.48%914.94K | -96.52%88.1K | 139.54%378K | -336.73%-1.24M | 12.38%1.69M |
| End cash Position | -19.87%12.64M | -19.87%12.64M | -16.60%18.3M | -51.38%12.32M | -47.54%16.71M | -54.68%15.77M | -54.68%15.77M | -32.76%21.94M | -31.52%25.34M | -22.95%31.85M |
| Free cash from | 37.08%-12.61M | 8.55%-5.67M | 34.08%-2.58M | 5.80%-4.86M | 111.44%545K | -61.29%-20.04M | -8,467.47%-6.2M | -14.57%-3.91M | -36.58%-5.16M | 2.62%-4.77M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data